NCT07210918Completed
Serum Trace Element Levels in Some Gynecological Diseases
Serum Trace Element Profiles in Women With Endometriosis, Ovarian and Endometrial Cancer: An ICP-MS-Based Comparative Study
Source: ClinicalTrials.gov · Last updated 24 Nov 2025
Brief summary (registry, in English)
The aim of this clinical study is to measure the levels of various trace elements in the blood serum of women with various gynecological diseases and to compare them with healthy controls. The main questions it aims to answer are: * Do trace element levels increase or decrease in endometriosis? * Do trace element levels increase or decrease in ovarian cancer patients? * Do trace element levels increase or decrease in endometrial cancer patients? Participants: Each member of the study group will visit the clinic only once and donate 5 ml of blood.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 30 Sept 2025
- Start date
- 24 Apr 2025
- Primary completion date
- 29 Sept 2025
- Lead sponsor
- Cumhuriyet University
- Diseases
- Endometriosis, Endometrial cancer, Ovarian cancer
- NCT number
- NCT07210918
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 24 Apr 2025 to the primary completion date, 29 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Chronic systemic diseases (e.g., chronic renal failure, liver disease, severe cardiac disease)
- Diseases that may affect metabolism or trace element levels (e.g., Wilson's disease, hemochromatosis)
- History of acute infection or inflammatory disease
- Psychiatric or cognitive disorders that preclude participation in the study
Lab values
- History of recurrent surgery or advanced metastatic cancer (as this may alter serum parameters)
Other
- Use of dietary supplements containing minerals or trace elements within the past 6 months
- Environmental or occupational heavy metal exposure (e.g., mining, metallurgy, battery industry workers)
- Pregnancy or breastfeeding
Who the study is looking for
- Not having received chemotherapy, radiotherapy or immunotherapy in the last three months
- For the endometriosis group: histopathologically or laparoscopically confirmed endometriosis
- For the ovarian cancer group: histopathologically confirmed epithelial ovarian cancer
- For the endometrial cancer group: histopathologically confirmed endometrial adenocarcinoma
- For the control group: healthy individuals who underwent surgery for benign gynecological causes (e.g., myoma, benign cyst) and who were not diagnosed with malignancy/endometriosis
Age in the registry: 18 years to 55 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sivas Cumhuriyet University Coordinator of this site? Confirm its status | Sivas | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.